(Q58021206)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

editorial

0 references

title

Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

main subject

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Morris Sherman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Michael Porayko

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Tram Tran

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

AASLD Practice Guidelines Committee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

30 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

793-796

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

Screening for liver cancer: the rush to judgment.

4 February 2020

cites work

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Randomized controlled trial of screening for hepatocellular carcinoma

21 January 2018

1 reference

Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program

21 January 2018

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

21 January 2018

1 reference

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

21 January 2018

1 reference

NCCN clinical practice guidelines in oncology: hepatobiliary cancers

21 January 2018

1 reference

Screening for liver cancer: results of a randomised controlled trial in Qidong, China

21 January 2018

1 reference

Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model

21 January 2018

1 reference

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis

21 January 2018

1 reference

Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis

21 January 2018

1 reference

Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.

21 January 2018

1 reference

Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances

21 January 2018

1 reference

Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome

21 January 2018

1 reference

Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

21 January 2018

1 reference

Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival

21 January 2018

1 reference

Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.

21 January 2018

1 reference

Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis

21 January 2018

1 reference

Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic

21 January 2018

1 reference

Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?

21 January 2018

1 reference

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

21 January 2018

1 reference

Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.

21 January 2018

1 reference

Long-term outcomes after resection versus transplantation for hepatocellular carcinoma within UCSF criteria

21 January 2018

1 reference

Scientific evidence underlying the ACC/AHA clinical practice guidelines

21 January 2018

1 reference

7 January 2021

Cost-effectiveness analysis of a two-stage screening intervention for hepatocellular carcinoma in Taiwan

1 reference

7 January 2021

Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis

1 reference

7 January 2021

Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?

1 reference

7 January 2021

Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma

1 reference

7 January 2021

Predictors of long-term disease-free survival after resection of hepatocellular carcinoma: two decades of experience at Chang Gung Memorial Hospital

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.25869

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22689409%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference